Greater China
VCs flock to Chinese chip designer Moore Threads
Moore Threads, a Chinese chip designer established as recently as last October by a team from Nvidia, has closed two funding rounds amounting to several billion renminbi.
FountainVest buys China logistics business
FountainVest Partners has agreed to acquire a majority stake in China-based CJ Rokin Logistics from Korea’s CJ Logistics for KRW733.8 billion ($661.3 million).
China's WuXi Diagnostics raises $150m
WuXi Diagnostics, a joint venture China diagnostics business set up by Hong Kong-listed pharmaceutical outsourcing giant WuXi AppTec and US-based Mayo Clinic has completed a $150 million Series B funding round.
Q&A: Affirma Capital's Ivo Philipps
Affirma Capital came into being 18 months ago as Standard Chartered’s private equity team spun out with most of the remaining balance sheet assets. COO Ivo Philipps explains the middle and back office transition
China's Fresh Capital hits $93m first close on Fund II
Fresh Capital, a Shanghai-based venture capital firm, has reached a first close of RMB600 million ($93 million) on its second renminbi-denominated fund.
VC-backed Appier files for Japan IPO
Appier, a Taiwan-based advertising technology provider, has filed for a JPY26.4 billion ($250 million) Japan IPO. It sets up exits for several VC investors, including Sequoia Capital.
Fund focus: LPs endorse Ocean Link's China tourism, tech thesis
Ocean Link has raised $580 million for a second fund targeting China travel, tourism and consumer technology assets, but the firm believes co-investment could take aggregate deployment to $1.4 billion
China's Clover Biopharmaceuticals gets $230m Series C
Chengdu-based Clover Biopharmaceuticals has raised $230 million in Series C funding led by GL Ventures and Temasek Holdings. Oceanpine Capital, OrbiMed, and Delos Capital all re-upped.
Primavera-led consortium takes control of Zhaopin
A consortium led by Primavera Capital has agreed to acquire a controlling position in Chinese recruitment website Zhaopin at an implied valuation of A$2.2 billion ($1.7 billion).
China's AnchorDx completes $40m Series C
AnchorDx, a China-based medical technology developer focused on DNA sequencing and diagnostics, has raised a $40 million Series C round led by OrbiMed and WuXi Huiying Investment.
COOs in Asia private equity: Horses for courses
The COO role is gradually becoming more prevalent in Asian private equity, but GPs struggle to find the right combination of financial skills and business acumen. The optimal candidate is often internal
MBK exits China's Apex International
MBK Partners has agreed to sell Apex International, China’s second-largest air freight forwarder, to Swiss logistics giant Kuehne + Nagel.
CPE leads $300m round for China's ANE Logistics
ANE Logistics, one of China’s top three less-than-truckload (LTL) logistics players, has raised $300 million in funding led by CPE. Greater Bay Area Fund, Hong Kong-listed NWS Holdings, Liumai Capital, and Huagai Capital also took part.
Temasek backs China industrial SaaS player
Temasek Holdings has led a RMB500 million ($77 million) round for Black Lake Technologies, a China-based software-as-a-service (SaaS) provider for manufacturers.
CPE leads $123m round for China's Wangjiahuan
Shenzhen-based agricultural products distributor Wangjiahuan has raised RMB800 million ($123 million) in a Series B extension led by CPE.
China's Regor Therapeutics raises $90m Series B
Lilly Asia Ventures (LAV) has led a $90 million Series B round for Regor Therapeutics, a Chinese drug developer specializing in bioinformatics.
China self-driving truck player Plus raises $200m
Plus, a China-based autonomous driving technology developer that specializes in trucks, has completed a $200 million round of funding led by Guotai Junan International, CPE, and automotive partssupplier Wanxiang.
China cancer screening business gains on Hong Kong debut
New Horizon Health, a China-based and venture capital-backed cancer early screening company, rose 215% on its trading debut following a HK$2 billion ($258 million) Hong Kong IPO.
China's CITIC sells US dental business
CITIC Capital Partners has exited US-based dental business DDS Lab – the private equity firm’s first acquisition in the US as a lead investor – to RoundTable Healthcare Partners for an undisclosed sum.
PE-backed JD Logistics set for Hong Kong listing
JD Logistics, a supply chain solutions and logistics provider that spun-out from Chinese online retailer JD.com, has filed for a Hong Kong IPO. The company has received $2.57 billion in private funding.
Chinese virotherapy specialist Binhui Biotech raises $93m
Wuhan-based Binhui Biotech has raised RMB600 million ($93 million) in Series C funding led by Shenzhen-based Share Capital. Other investors include CICC Capital, Vertex Ventures China and Qianhai FOF under Shenzhen Capital Group.
Q&A: Gushcloud's Althea Lim
Singapore’s Gushcloud, a VC-backed influencer talent agency and content producer, operates at the frontlines of a young, fast-changing media landscape. CEO Althea Lim tours the latest developments
China teahouse chain Nayuki pursues Hong Kong IPO
Nayuki, a private equity-backed Chinese teahouse chain also known as Naixuecha, has filed for a Hong Kong IPO. It comes on the heels of a $100 million Series C round.
Deal focus: Asia Green Fund secures DuPont carve-out
Asia Green Fund reunited with the team at special situations investor BroadPeak Global for the $510 million acquisition of DuPont's clean energy unit. Driving expansion in China is now the priority